Pfizer revises Resapp offer on heels of failed data confirmation study
https://www.bioworld.com/articles/520030-pfizer-revises-resapp-offer-on-heels-of-failed-data-confirmation-study?v=preview
Pfizer revises Resapp offer on heels of failed data confirmation...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #